SA PRO
Free Account
Themes
Quest Diagnostics IncorporatedDGXNYSE
Loading
OverviewIntelligenceChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts are neutral — opinion is divided on direction.

Consensus Rating
Hold
20 analysts·High coverage
45%
Rating Distribution
Strong Buy
00%
Buy
945%
Hold
1155%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Feb 12, 2026Mizuho Securities
Quest Diagnostics price target raised to $235 from $210 at Mizuho
Target:$235.00
+12.3%from $209.32
Feb 11, 2026UBS
Quest Diagnostics price target raised to $210 from $190 at UBS
Target:$210.00
+1.6%from $206.72
Feb 11, 2026Truist Financial
Quest Diagnostics price target raised to $220 from $205 at Truist
Target:$220.00
+7.0%from $205.63
Feb 11, 2026Evercore ISI
Quest Diagnostics price target raised to $220 from $190 at Evercore ISI
Target:$220.00
+7.1%from $205.43
Feb 11, 2026Robert W. Baird
Quest Diagnostics price target raised to $219 from $203 at Baird
Target:$219.00
+6.6%from $205.35
Feb 10, 2026Jefferies
Quest Diagnostics price target raised to $220 from $215 at Jefferies
Target:$220.00
+7.2%from $205.24
Jan 30, 2026Barclays
Quest Diagnostics upgraded to Overweight from Equal Weight at Barclays
Target:$210.00
+15.2%from $182.35
Oct 27, 2025Piper Sandler
Quest Diagnostics price target raised to $200 from $190 at Piper Sandler
Target:$200.00
+9.8%from $182.18
Oct 22, 2025Truist Financial
Quest Diagnostics (DGX) PT Raised at Truist; '3Q Ahead As Core Trends Remain Strong'
Target:$205.00
+11.0%from $184.64
Oct 22, 2025Morgan Stanley
Quest Diagnostics price target raised to $207 from $191 at Morgan Stanley
Target:$207.00
+13.0%from $183.18
Oct 22, 2025Barclays
Quest Diagnostics price target raised to $195 from $190 at Barclays
Target:$195.00
+6.5%from $183.18
Oct 21, 2025Jefferies
Quest Diagnostics price target raised to $215 from $200 at Jefferies
Target:$215.00
+17.3%from $183.34
Oct 21, 2025Leerink Partners
Quest Diagnostics price target raised to $210 from $203 at Leerink
Target:$210.00
+14.1%from $184.10
Oct 17, 2025UBS
Quest Diagnostics price target raised to $190 from $180 at UBS
Target:$190.00
+1.7%from $186.82
Oct 17, 2025Mizuho Securities
Quest Diagnostics price target raised to $210 from $190 at Mizuho
Target:$210.00
+12.4%from $186.82
Oct 14, 2025Truist Financial
Quest Diagnostics price target raised to $195 from $192 at Truist
Target:$195.00
+6.0%from $184.00
Oct 8, 2025Evercore ISI
Quest Diagnostics price target raised to $190 from $185 at Evercore ISI
Target:$190.00
+4.5%from $181.89
Oct 2, 2025Barclays
Quest Diagnostics price target raised to $190 from $185 at Barclays
Target:$190.00
+4.4%from $182.07
Aug 25, 2025Robert W. Baird
Quest Diagnostics downgraded to Neutral from Outperform at Baird
Target:$194.00
+8.6%from $178.66
Jul 23, 2025Evercore ISI
Quest Diagnostics price target raised to $185 from $180 at Evercore ISI
Target:$185.00
+8.5%from $170.48
Apr 2, 2025Redburn Partners
Quest Diagnostics initiated with a Buy at Redburn Atlantic
Target:$195.00
+16.1%from $167.96
Feb 3, 2025Piper Sandler
Quest Diagnostics price target raised to $180 from $165 at Piper Sandler
Target:$180.00
+10.8%from $162.47
Jan 31, 2025Truist Financial
Quest Diagnostics price target raised to $182 from $172 at Truist
Target:$182.00
+11.6%from $163.10
Jan 31, 2025Robert W. Baird
Quest Diagnostics price target raised to $189 from $184 at Baird
Target:$189.00
+15.9%from $163.10
Oct 23, 2024Citigroup
Quest Diagnostics price target raised to $185 from $165 at Citi
Target:$185.00
+17.5%from $157.47

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance